Intelligence Platform
Patents
Browse 111 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6485746
Controlled-release sedative-hypnotic compositions and methods related thereto
expired patentUS 6469166
Thiophenopyrimidines
expired patentUS 6440960
CRF receptor antagonists and methods relating thereto
expired patentUS 6384221
Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-&agr;]-pyrimidin-7-yl}phen
expired patentUS 6379670
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic pr
expired patentUS 6369033
Methods for treatment of multiple sclerosis using peptide analogues at position 91 of huma
expired patentUS 6348466
CRF receptor antagonists and methods relating thereto
expired patentUS 6329499
Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic
expired patentUS 6288060
Amino substituted pyrimidines and triazines
expired patentUS 6255310
Thiophenopyrimidines
expired patentUS 6251396
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic pr
expired patentUS 6239268
Interleukin-1 type 3 receptors
expired patentUS 6211195
CRF antagonistic thiophenopyridines
expired patentUS 6197926
Methods for treatment of diabetes using peptide analogues of insulin
expired patentUS 6133276
Compounds and methods for increasing endogenous levels of corticotropin-releasing factor
expired